Ocular Pulse Amplitude를 이용한 타플루프로스트의 임상적 효과 분석

다국어 초록 (Multilingual Abstract)

Purpose: To analyze the clinical effectiveness of tafluprost used in the treatment of glaucoma, using ocular pulse amplitude (OPA) measurements with dynamic contour tonometry (DCT). Methods: Sixty patients (119 eyes) with normal tension glaucoma (NTG) or primary open angle glaucoma (POAG) treated with tafluprost or other eyedrops were investigated in the present study. Intraocular pressure (IOP) was measured with Goldmann applanation tonometry (GAT), and OPA was measured with DCT, before and after treatment, retrospectively. Results: In 20 patients treated with tafluprost, IOP decreased from 17.1 mm Hg before treatment to 13.0 mm Hg 3 months after treatment (24.0% descent rate), and OPA decreased from 2.35 to 1.57 (33.2% descent rate). For 20 patients who switched from another monotherapy to tafluprost, IOP decreased from 15.7 mm Hg to 13.2 mm Hg from 15.7 mm Hg (15.3%) and OPA from 2.38 to 1.69 (27.7%). Conclusions: Tafluprost used to treat glaucoma has a large OPA and IOP lowering effect and, therefore can be applied to patients who have a large OPA with glaucoma progression in spite of well controlled IOP.

참고문헌 (Reference)

1 이나영, "정상안압녹내장 환자에서 혈액검사를 통한 전신적 인자에 대한 분석" 대한안과학회 51 (51): 241-247, 2010

2 서울, "정상안압 및 원발개방각녹내장 사이의 Primary Vascular Dysregulation 비교" 대한안과학회 51 (51): 393-400, 2010

3 Katz LJ, "Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension" 149 : 661-671, 2010

4 Georgopoulos GT, "The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow" 80 : 54-58, 2002

5 Harris A, "The role of optic nerve blood flow in the pathogenesis of glaucoma" 18 : 345-353, 2005

6 Flammer J, "The impact of ocular blood flow in glaucoma" 21 : 359-393, 2002

7 Weizer JS, "The clinical utility of dynamic contour tonometry and ocular pulse amplitude" 16 : 700-703, 2007

8 Fogagnolo P, "Test-retest variability of intraocular pressure and ocular pulse amplitude for dynamic contour tonometry: a multicentre study" 94 : 419-423, 2010

9 Pantcheva MB, "Tafluprost: a novel prostaglandin analog for treatment of glaucoma" 28 : 707-715, 2011

10 Hommer A, "Switching patients from preserved prostaglandin- analog monotherapy to preservative-free tafluprost" 5 : 623-631, 2011

11 Frayer WC, "Some consequences of ciliary process swelling in the rabbit and in the human" 74 : 107-121, 1976

12 Izumi N, "Short-term effects of topical tafluprost on retinal blood flow in cats" 24 : 521-526, 2008

13 Pozarowska D, "Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension" 4 : 1229-1236, 2010

14 Grieshaber MC, "Relationship between ocular pulse amplitude and systemic blood pressure measurements" 87 : 329-334, 2009

15 Dastiridou AI, "Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure" 50 : 5718-5722, 2009

16 Kac MJ, "Ocular pulse amplitude in patients with asymmetric primary open-angle glaucoma" 36 : 727-732, 2011

17 Stalmans I, "Ocular pulse amplitude in normal tension and primary open angle glaucoma" 17 : 403-407, 2008

18 Kaufmann C, "Ocular pulse amplitude in healthy subjects as measured by dynamic contour tonometry" 124 : 1104-1108, 2006

19 Grover DS, "Ocular perfusion pressure and glaucoma" 51 : 19-25, 2011

20 Hoffmann EM, "Intraocular pressure and ocular pulse amplitude using dynamic contour tonometry and contact lens tonometry" 4 : 4-, 2004

21 Punjabi OS, "Dynamic contour tonometry: principle and use" 34 : 837-840, 2006

22 서장원, "Dynamic Contour Tonometry와 골드만 압평 안압계의 비교" 대한안과학회 50 (50): 242-246, 2009

23 Vulsteke C, "Correlation between ocular pulse amplitude measured by dynamic contour tonometer and visual field defects" 246 : 559-565, 2008

24 Anderson MF, "Comparison of the utility of pascal dynamic contour tonometry with goldmann applanation tonometry in routine clinical practice" 2012

25 Aihara M, "Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension" 4 : 163-170, 2010

26 Grieshaber MC, "Blood flow in glaucoma" 16 : 79-83, 2005

27 Detorakis ET, "Applanation tonometry versus dynamic contour tonometry in eyes treated with latanoprost" 19 : 194-198, 2010